Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Conmed (CNMD) EBIAT (2016 - 2025)

Conmed (CNMD) has disclosed EBIAT for 11 consecutive years, with $24.1 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, EBIAT rose 61.66% year-over-year to $24.1 million, compared with a TTM value of $9.5 million through Dec 2020, down 66.75%, and an annual FY2025 reading of $47.1 million, down 64.47% over the prior year.
  • EBIAT was $24.1 million for Q4 2020 at Conmed, up from $6.8 million in the prior quarter.
  • Across five years, EBIAT topped out at $46.7 million in Q4 2017 and bottomed at -$27.4 million in Q2 2020.
  • Average EBIAT over 5 years is $7.5 million, with a median of $6.8 million recorded in 2016.
  • The sharpest move saw EBIAT skyrocketed 596.12% in 2017, then crashed 581.12% in 2020.
  • Year by year, EBIAT stood at $6.7 million in 2016, then surged by 596.12% to $46.7 million in 2017, then plummeted by 66.48% to $15.7 million in 2018, then fell by 4.6% to $14.9 million in 2019, then surged by 61.66% to $24.1 million in 2020.
  • Business Quant data shows EBIAT for CNMD at $24.1 million in Q4 2020, $6.8 million in Q3 2020, and -$27.4 million in Q2 2020.